₁₅Stephen B Hanauer

Summary for 2004 [at-glance overview of Stephen B Hanauer work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Stephen B Hanauer. According to available data, in 2004 Stephen B Hanauer published at least 15 articles. This work was completed in collaboration with several authors including Rutgeerts, Paul and Lichtenstein, Gary R. Many other authors have collaborated with Stephen B Hanauer as well. There is at least one grant awarded to support this work. All time total of the grant awards on file exceeds $1,506,124.

Stephen B Hanauer is a key opinion leader in numerous areas including Crohn Disease, Anti-Inflammatory Agents, Non-Steroidal, Gastrointestinal Agents, Mesalamine, Aminosalicylic Acids. This author's highest rank is 1 when compared to all other authors using the keyword Aminosalicylic Acids. Analysis of the article abstracts and the titles suggests that Stephen B Hanauer professional interests are focused around "inflammatory bowel disease", "treatment crohn disease" and "tumor necrosis factor". These might also be referred to as "crohn disease", "ulcerative colitis" or "inflammatory bowel". Statistical analysis shows that Stephen B Hanauer's writing is likely to contains terms "disease", "crohn", "colitis", "ulcerative", "treatment" and "clinical".

Unfortunately, there is not enough information to establish Stephen B Hanauer affiliation. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Stephen B Hanauer]

Do you know Stephen B Hanauer who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to Stephen B Hanauer]

₄₅Hanauer, S B

Year 2004 Charts [Stephen B Hanauer frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Stephen B Hanauer publication and funding history for the range of years]

Emails (4) [email addresses extracted from Stephen B Hanauer affiliations]

hidden to prevent spam, click here to reveal

Stephen B Hanauer Coauthors (20) [all coauthors with the number of joint publications]

explore visually

3

₂₃Rutgeerts, Paul

2

₁₄Lichtenstein, Gary R

2

2

1

1

1

1

1

1

1

₅Rachmilewitz, Daniel

1

₄Bala, Mohan

1

₄Peppercorn, Mark A

1

₃Colombel, Jean Frederic

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (13) [condensed summary of the Stephen B Hanauer affiliations, the leading number and the color conveys importance]

₂Section of Gastroenterology and Nutrition, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois, USA.
₁Section of Gastroenterology and Nutrition, University of Chicago, IL, USA.
₁University of Chicago, IL 60637, USA.
₁University of Chicago Medical Center, Department of Medicine, Gastroenterology & Nutrition, MC 9028, 5841 S Maryland Avenue, Chicago, IL 60637, USA.
₁Department of Medicine, University of Chicago Medical Center, Chicago, Illinois, USA.
₁Department of Gastroenterology and Nutrition, University of Chicago Medical Center, IL 60637, USA.
₁University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
₁Department of Medicine and the Section of Gastroenterology and Nutrition, University of Chicago, Chicago, Illinois, USA.
₁Section of Gastroenterology and Nutrition, University of Chicago Medical Center, 5841 South Maryland Avenue, MC 4076, Chicago, IL 60637, USA.
₁Department of Medicine and Clinical Pharmacology, Section of Gastroenterology and Nutrition, University of Chicago, Illinois 60637, USA.
₁University of Chicago Pritzker School of Medicine, Illinois, USA.
₁Afdeling Gastroenterologie, Universitair Ziekenhuis Gasthuisberg, Leuven, Belgium.
₁Section of Gastroenterology, Department of Medicine, University of Chicago Hospitals, Chicago, Illinois, USA.

Key Opinion Leader In [Stephen B Hanauer is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₁Aminosalicylic Acids | ₁Biological Therapy | ₂Mesalamine | ₄Anti-Inflammatory Agents, Non-Steroidal | ₄Crohn Disease | ₅Gastrointestinal Agents | ₂₀Colitis, Ulcerative | ₅₁Remission Induction | ₅₅Antibodies, Monoclonal | ₈₅Double-Blind Method | ₁₀₈Drug Administration Schedule | ₂₁₀Treatment Outcome | ₂₄₅Randomized Controlled Trials as Topic | ₂₅₆Severity of Illness Index | ₅₃₀Dose-Response Relationship, Drug

Keywords (32) [keywords assigned to Stephen B Hanauer articles by PubMed, the leading number and the color conveys importance]

₁₄Humans | ₁₀Crohn Disease | ₇Treatment Outcome | ₅Female | ₅Anti-Inflammatory Agents, Non-Steroidal | ₅Antibodies, Monoclonal | ₄Gastrointestinal Agents | ₄Mesalamine | ₄Colitis, Ulcerative | ₄Male | ₄Double-Blind Method | ₃Drug Administration Schedule | ₃Aminosalicylic Acids | ₃Dose-Response Relationship, Drug | ₃Severity of Illness Index | ₃Randomized Controlled Trials as Topic | ₃Adult | ₃Remission Induction | ₃Biological Therapy | ₂Colorectal Neoplasms | ₂Chemoprevention | ₂Inflammatory Bowel Diseases | ₂Anti-Bacterial Agents | ₂Antibodies | ₂Digestive System Surgical Procedures | ₂Quality of Life | ₁Antimetabolites | ₁Drainage | ₁Glucocorticoids | ₁Follow-Up Studies | ₁Questionnaires | ₁Tumor Necrosis Factor-alpha

Stephen B Hanauer Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Stephen B Hanauer might be a good expert witness on these terms]

₅₄disease | ₄₂crohn | ₃₁colitis | ₂₉ulcerative | ₂₅treatment | ₂₂clinical | ₁₈therapy | ₁₈patients | ₁₂inflammatory | ₁₂mesalamine | ₁₁infliximab | ₁₁bowel | ₁₁trials | ₁₁maintenance | ₁₀pentasa | ₉aminosalicylates | ₉management | ₉placebo | ₉efficacy | ₉biologic | ₈cdai | ₇therapies | ₇controversies | ₇groups | ₆strategies | ₆factor | ₆meta-analysis | ₆active | ₆necrosis | ₆compared | ₅safety | ₅moderate
₃₇crohn disease | ₂₉ulcerative colitis | ₈inflammatory bowel | ₇bowel disease | ₆necrosis factor | ₆treatment crohn | ₅efficacy safety | ₅mild moderate | ₅tumor necrosis | ₅therapy ulcerative | ₄colitis crohn | ₄moderate crohn | ₄episodic treatment | ₄mesalamine derivatives | ₄active crohn | ₃diagnosis ulcerative | ₃lifelong management | ₃biologic agents | ₃etiology pathogenesis | ₃upper quadrant | ₃maintenance therapy | ₃double-blind placebo-controlled | ₃fever right | ₃quadrant pain | ₃treatment active | ₃ct scan | ₃clinical trials | ₃biologic therapies | ₃clinical studies | ₃right upper | ₃management mild | ₃weeks gestation
₇inflammatory bowel disease | ₆treatment crohn disease | ₅tumor necrosis factor | ₅therapy ulcerative colitis | ₄moderate crohn disease | ₄ulcerative colitis crohn | ₄mild moderate crohn | ₄active crohn disease | ₃diagnosis ulcerative colitis | ₃treatment active crohn | ₃medical therapy ulcerative | ₃right upper quadrant | ₃fever right upper | ₃upper quadrant pain | ₃colitis crohn disease | ₃maintenance crohn disease | ₃management mild moderate | ₂6-week disease lifelong | ₂factor antagonists crohn | ₂ulcerative colitis diagnosis | ₂meta-analysis double-blind placebo-controlled | ₂etiology pathogenesis diagnosis | ₂crohn disease meta-analysis | ₂pregnant woman weeks | ₂disease remission 6-mercaptopurine | ₂placebo 2-year trial | ₂overview randomized clinical | ₂mesalamine placebo 2-year | ₂maintenance episodic treatment | ₂incidence importance antibody | ₂crohn 6-week disease | ₂baseline final visit

Reader's Comments (0) [comments posted by readers of Stephen B Hanauer profile]